Institutional investors purchased a net $575.4 thousand shares of ICPT during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 39.28% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
| Individual stakeholders | 62.96% |
| Other institutional | 29.01% |
| Mutual fund holders | 10.28% |